Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.9900
+0.0500 (2.58%)
NASDAQ· Last Trade: Jul 3rd, 2:11 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors